Steven M. Ferguson,
currently serves as Special Advisor for Technology Transfer for the NIH Office of Technology Transfer where he has worked since 1990. The biomedical technology transfer program at NIH is one of the world’s largest with a portfolio that includes about 1,300 active licenses, 400 of which report product sales in aggregate greater than $6B per year. A registered Patent Agent and a Certified Licensing Professional (CLP), Mr. Ferguson is faculty and Technology Transfer Department Chair at the Foundation for Advanced Education in the Sciences (FAES) Graduate School at NIH and the Biotechnology Industry Organization “BIO Boot Camp” along with being an Executive-in-Residence at the Johns Hopkins University Cary School of Business. He has received the AUTM President’s Award (AUTM Band), the NIH Director’s Award, the FAES Instruction Award, three “Deal of Distinction” awards from the Licensing Executive Society, six Federal Laboratory Consortium Awards, and fifteen NIH Merit Awards in recognition of his service and activities in the area of technology transfer.
Andrew J. Maas,
is the Assistant Vice President for Research and Director of the Office of Innovation & Technology Commercialization at Louisiana State University. Andy is an engineer by training with a MS in civil engineering from Brigham Young University and the University of Texas at Austin, respectively. He is a licensed professional engineer in the state of Texas where he worked for several years and grew a start-up engineering company from two individuals to 14 employees. Andy also has a JD from the University of Akron School of Law, and a LLM with a focus on intellectual property. His research focus for his LLM degree was "early stage patent valuation under the new America Invents Act." He has been published in the Journal of the United States Patent and Trademark Office, and in Cement and Concrete Research.
is Director of Corporate Engagement for the Massachusetts Institute of Technology’s Environmental Solutions Initiative. He was previously a Licensing Officer for MIT, where he also led international technology transfer capacity-building engagements. Before joining MIT, Chris worked in engineering, marketing, M&A and executive management for international energy and technology companies. He was on the founding teams of two start-ups, as VP Sales & Marketing and CEO, and is the lead inventor on two issued patents. Chris also spent ten years as a consultant and investor, raising and negotiating financing for early-stage companies. He is a Certified Licensing Professional, a Registered Technology Transfer Professional, and a published author in peer-reviewed journals. He received the Licensing Executive Society Deals of Distinction award in 2011. He lectures, consults and provides assessments and audits worldwide on university technology strategy, IP patenting, valuation, policies and capacity building, partnerships with industry, start-up mentoring, and entrepreneurial ecosystems. Chris served on AUTM's Board of Directors from 2017 to 2020. He has an MBA from MIT, has lived and worked in the US, Canada, South America and Europe, and is fluent in French and Spanish.
is currently the Associate Vice President for Commercialization at Texas A&M University. He has over 20 years of experience negotiating and managing early-stage IP licensing deals in a wide variety of industries and applications, with both existing companies and new ventures. In addition to a Master’s degree in Business with a finance concentration, he has also taken intermediate and advanced IP valuation courses from the Licensing Executives Society and the Business Development Academy, and typically creates a discounted cash-flow IP valuation model to support negotiations for every licensing deal he participates in (n > 50).
The Focus IP Group,
provides a variety of consulting services in intellectual property matters, including serving as an Expert Witness in intellectual property disputes, technology scouting, technology transfer and teaching the commercialization of early stage technologies. For 15 years, Dr. Ashley Stevens
led Boston University’s Office of Technology Transfer. He then became Special Assistant to the Vice President for Research for two years before retiring from full time employment at BU. For ten years he was a Lecturer in the Strategy and Innovation Department in Boston University’s Questrom School of Business, where he taught two graduate-level, inter-disciplinary courses on Technology Commercialization. Before joining Boston University he was Director of the Office of Technology Transfer at the Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School. Dr. Stevens holds a Master of Arts and a Doctor of Philosophy in Physical Chemistry from Oxford University. He is a Certified Licensing Professional and a Registered Technology Transfer Professional.
Debora R. Stewart, CPA,
is a Managing Director with Invotex. Known for auditing with a smile, Invotex is a consulting firm that specializes in Royalty Audits. Ms. Stewart is a Certified Public Accountant with more than 25 years experience working with Fortune 100 and 500 corporations, leading research universities, government entities and their counsel in the intellectual property area. Her firm is known for their ability to uncover large underpayments while preserving the licensor-licensee relationship. Invotex’s royalty audit statistics show that misreporting has occurred in 86% of the licensees and Invotex has audited. Invotex has uncovered over $400 million for their grateful clients. She was at the forefront of the patent royalty audit industry as one of the first professionals who understood the unique relationship between the licensor and licensee. She is dedicated to helping clients proactively manage their license royalty reporting and revenue., and arguably, has managed more patent royalty audits than anyone else in the industry.